Posts by Sandra Ansanay-Alex
Hedera Dx Secures €15 Million Series A
Hedera Dx Raises €15M Series A to Expand Access to Precision Oncology Across Europe Hedera Dx, a Vaud-Based techbio company advancing precision cancer care, announced the successful close of a €15 million Series A financing round. The round was led by Vsquared Ventures, with new investor Tesi joining and strong support from existing backers…
Read MoreTimeline® Named Milestone 1 Award Winner in XPRIZE Healthspan Competition
Timeline®, a leading longevity biotech company (parent company Amazentis in Canton of Vaud) and maker of Mitopure®, has been named a Milestone 1 Award Winner in the prestigious XPRIZE Healthspan competition. Selected from hundreds of global entrants, Timeline is among the Top 40 international teams recognized for advancing innovative, safe, and science-backed solutions to extend…
Read MoreTheia Holding SA Merges With HL Technology SA
Theia Holding SA, a leader in precision technologies for the dental, orthopaedic, and medical fields and HL Technology®, an innovator recognised for patented breakthroughs in medical engineering, are merging. A Strategic Partnership for Innovation and Excellence The merger strengthens Theia Holding SA’s leadership in key sectors — dental, orthopaedic, and broader medical markets…
Read MoreTOP 100 Swiss Startup Award: Vote Now!
The TOP 100 Swiss Startup Award is back! Vote until 20 July 2025 for your favourite Life Sciences start-up. Every year, the TOP 100 Swiss Startup Award showcases the 100 most innovative and promising Swiss startups chosen by a 100-strong jury of leading investors and experts. The TOP 100 Public Vote runs parallel to the expert jury…
Read MoreBioAlps Networking Day
The BioAlps Networking Day attracts each year about 350 key players from the Swiss Health Valley🇨🇭 region: representatives from academia, startups, government, and media gather to share the latest trends in Life Sciences and connect with each other. BioAlps Networking Day 2026 BioAlps flagship event will take place on 19 November 2026 at Beaulieu Lausanne.…
Read MoreBIND – BioInnovation Day
BIND – BioInnovation Day is an exclusive technology showcase and networking event that brings together Life Sciences innovators and investors. The BIND is an event that was initially organised by UNITEC, the Technology transfer office of the University of Geneva (UNIGE) and The Hospital of Geneva, and the PACTT, the Technology transfer office…
Read MoreRepronovo raises $65 million in series A
ReproNovo, a Vaud-Based company dedicated to developing innovative treatments for reproductive medicine and women’s health, announced the successful closing of a $65 million Series A financing round. The round was led by Jeito Capital, co-led by AXA IM Alts and founding investor M Ventures, with strong syndicate support from Ysios Capital and ALSA Ventures. The…
Read MoreOneDoc Merges With Medicosearch
OneDoc, the leading Swiss platform for booking online medical appointments, has acquired Medicosearch. This transaction is another important step in the development of the Geneva-based company, consolidating its position as the leading player in digital healthcare in Switzerland, with over 13,000 registered healthcare professionals and more than 350,000 consultations booked online each month. The new…
Read MoreDePoly raised $23 Million
The Valais-based scale-up and HES-SO Valais-Wallis spinoff prepares to demonstrate industrial-scale implementation of its revolutionary technology that transforms plastic waste into virgin-quality raw materials without fossil fuels. Every year, millions of tons of PET and polyester waste end up in landfills or are incinerated, yet sustainable recycling solutions remain limited. DePoly – the leading…
Read MoreNestlé Opens A New R&D Centre Dedicated To Biotech And Deeptech In Orbe
Nestlé announced the strengthening of its R&D expertise in biotechnology and the creation of a new centre for deep tech, to boost its innovation pipeline and increase efficiency in research, innovation and operations. The investments will be unlocked by a leaner R&D organization, more agile ways of working, a focused project portfolio and the redeployment of existing R&D…
Read More